americans 16 and over, concluding it is too soon to offer booster shots for everyone. the fda expresses several concerns about lack of safety and efficacy data for booster shots in young adults. joining me to discuss, the associate dean of global health at the university of alabama in birmingham. good to see you, dr. sag. are you disappointed or in agreement? >> i am mostly in agreement. we said from the beginning we're going to follow the data. data for people over the age of 65 and those with underlying conditions and those people who especially have immuno compromised states are ones we have data for to show this. we don't have data yet for people who are younger who don't have these conditions. they're following the data. this is a work in progress. expect this to be incremental improvement for third shot. we're going to be in this for the long haul. >> you will encourage patients that are at risk, individuals or
Related Keywords
Us , Everyone , Concerns , Data , Adults , Booster Shots , Fda , Safety , Dover , Black , Efficacy , 16 , Health , Dr , Agreement , Beginning , University Of Alabama In Birmingham , Sag , Associate Dean , People , Don T , States , Ones , Conditions , Age , We Dont Have Data , 65 , Risk , Shot , Improvement , Haul , Work In Progress , Patients , Individuals ,
comparemela.com © 2020. All Rights Reserved.